PTPRC and neoplasm: The immune and tumor epithelial ROIs were clearly separated, with distinct enrichment of epithelial (e.g., EpCAM, PanCK) and immune (CD3, CD45) cell markers, whereas mouse IgG2a antibody (negative control) showed minimal signal (Supplemental Figure 7E).